학술논문
Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study
Document Type
Article
Author
Source
Ophthalmology Retina; December 2020, Vol. 4 Issue: 12 p1138-1145, 8p
Subject
Language
ISSN
24687219; 24686530
Abstract
To investigate the inter-individual variability in duration of anti-vascular endothelial growth factor (VEGF) treatment effect in neovascular age-related macular degeneration (nvAMD).